176 related articles for article (PubMed ID: 24205145)
1. Predictors of short- and long-term mortality in males and females with hip fracture - a prospective observational cohort study.
Diamantopoulos AP; Hoff M; Hochberg M; Haugeberg G
PLoS One; 2013; 8(10):e78169. PubMed ID: 24205145
[TBL] [Abstract][Full Text] [Related]
2. Predictors of Hip Fracture Despite Treatment with Bisphosphonates among Frail Older Adults.
Zullo AR; Sorial MN; Lee Y; Lary CW; Kiel DP; Berry SD
J Am Geriatr Soc; 2020 Feb; 68(2):256-260. PubMed ID: 31580488
[TBL] [Abstract][Full Text] [Related]
3. Anti-Osteoporosis Medications Associated with Decreased Mortality after Hip Fracture.
Wang PW; Li YZ; Zhuang HF; Yu HM; Cai SQ; Xu H; Chen ZH; Lin JK; Yao XD
Orthop Surg; 2019 Oct; 11(5):777-783. PubMed ID: 31429532
[TBL] [Abstract][Full Text] [Related]
4. Post-fracture prescribed calcium and vitamin D supplements alone or, in females, with concomitant anti-osteoporotic drugs is associated with lower mortality in elderly hip fracture patients: a prospective analysis.
Nurmi-Lüthje I; Lüthje P; Kaukonen JP; Kataja M; Kuurne S; Naboulsi H; Karjalainen K
Drugs Aging; 2009; 26(5):409-21. PubMed ID: 19552493
[TBL] [Abstract][Full Text] [Related]
5. Oral bisphosphonates are associated with reduced mortality after hip fracture.
Beaupre LA; Morrish DW; Hanley DA; Maksymowych WP; Bell NR; Juby AG; Majumdar SR
Osteoporos Int; 2011 Mar; 22(3):983-91. PubMed ID: 21052642
[TBL] [Abstract][Full Text] [Related]
6. Undertreatment of osteoporosis following hip fracture: a retrospective, observational study in Singapore.
Chau YT; Nashi N; Law LS; Goh RKH; Choo SX; Seetharaman SK
Arch Osteoporos; 2020 Sep; 15(1):141. PubMed ID: 32918196
[TBL] [Abstract][Full Text] [Related]
7. Short- and long-term mortality in males and females with fragility hip fracture in Norway. A population-based study.
Diamantopoulos AP; Hoff M; Skoie IM; Hochberg M; Haugeberg G
Clin Interv Aging; 2013; 8():817-23. PubMed ID: 23861581
[TBL] [Abstract][Full Text] [Related]
8. Adherence With Bisphosphonates and Long-Term Risk of Hip Fractures: A Nested Case-Control Study Using Real-World Data.
Shalev V; Sharman Moser S; Goldshtein I; Yu J; Weil C; Ish-Shalom S; Rouach V; Chodick G
Ann Pharmacother; 2017 Sep; 51(9):757-767. PubMed ID: 28535690
[TBL] [Abstract][Full Text] [Related]
9. What is a reasonable rate for specific osteoporosis drug therapy in older fragility fracture patients?
Gosch M; Bail HJ; Grueninger S; Stumpf U; Kammerlander C; Wicklein S
Arch Osteoporos; 2020 Feb; 15(1):20. PubMed ID: 32088765
[TBL] [Abstract][Full Text] [Related]
10. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
[TBL] [Abstract][Full Text] [Related]
11. Effect of Bisphosphonates on Fracture Outcomes Among Frail Older Adults.
Zullo AR; Zhang T; Lee Y; McConeghy KW; Daiello LA; Kiel DP; Mor V; Berry SD
J Am Geriatr Soc; 2019 Apr; 67(4):768-776. PubMed ID: 30575958
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the association between bisphosphonate treatment survival in Danish hip fracture patients-a nationwide register-based open cohort study.
Bondo L; Eiken P; Abrahamsen B
Osteoporos Int; 2013 Jan; 24(1):245-52. PubMed ID: 22638712
[TBL] [Abstract][Full Text] [Related]
13. Hip fracture rate and osteoporosis treatment in Ontario: A population-based retrospective cohort study.
AbuAlrob H; Ioannidis G; Jaglal S; Costa A; Grifith LE; Thabane L; Adachi JD; Cameron C; Hillier L; Lau A; Papaioannou A
Arch Osteoporos; 2024 Jun; 19(1):53. PubMed ID: 38918265
[TBL] [Abstract][Full Text] [Related]
14. Does previous fragility fracture impact upon mortality in a hip fracture cohort? a retrospective study.
Miller PE; Murphy EP; Murphy R; Doran C; McKenna D; Murphy B; Doyle R; Hurson C
Ir J Med Sci; 2023 Oct; 192(5):2243-2249. PubMed ID: 36715792
[TBL] [Abstract][Full Text] [Related]
15. Orthogeriatric co-management improves the outcome of long-term care residents with fragility fractures.
Gosch M; Hoffmann-Weltin Y; Roth T; Blauth M; Nicholas JA; Kammerlander C
Arch Orthop Trauma Surg; 2016 Oct; 136(10):1403-9. PubMed ID: 27501701
[TBL] [Abstract][Full Text] [Related]
16. Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral Fractures: An Instrumental Variable Analysis.
Desai RJ; Mahesri M; Abdia Y; Barberio J; Tong A; Zhang D; Mavros P; Kim SC; Franklin JM
JAMA Netw Open; 2018 Jul; 1(3):e180826. PubMed ID: 30646034
[TBL] [Abstract][Full Text] [Related]
17. Fracture mortality: associations with epidemiology and osteoporosis treatment.
Sattui SE; Saag KG
Nat Rev Endocrinol; 2014 Oct; 10(10):592-602. PubMed ID: 25091729
[TBL] [Abstract][Full Text] [Related]
18. Should patients with exceptional longevity be treated for osteoporosis after a hip fracture?
Barceló M; Casademont J; Mascaró J; Gich I; Torres OH
Age Ageing; 2024 Jun; 53(6):. PubMed ID: 38899445
[TBL] [Abstract][Full Text] [Related]
19. Global Epidemiology of Hip Fractures: Secular Trends in Incidence Rate, Post-Fracture Treatment, and All-Cause Mortality.
Sing CW; Lin TC; Bartholomew S; Bell JS; Bennett C; Beyene K; Bosco-Levy P; Bradbury BD; Chan AHY; Chandran M; Cooper C; de Ridder M; Doyon CY; Droz-Perroteau C; Ganesan G; Hartikainen S; Ilomaki J; Jeong HE; Kiel DP; Kubota K; Lai EC; Lange JL; Lewiecki EM; Lin J; Liu J; Maskell J; de Abreu MM; O'Kelly J; Ooba N; Pedersen AB; Prats-Uribe A; Prieto-Alhambra D; Qin SX; Shin JY; Sørensen HT; Tan KB; Thomas T; Tolppanen AM; Verhamme KMC; Wang GH; Watcharathanakij S; Wood SJ; Cheung CL; Wong ICK
J Bone Miner Res; 2023 Aug; 38(8):1064-1075. PubMed ID: 37118993
[TBL] [Abstract][Full Text] [Related]
20. Incidence rates of fragility hip fracture in middle-aged and elderly men and women in southern Norway.
Diamantopoulos AP; Rohde G; Johnsrud I; Skoie IM; Johnsen V; Hochberg M; Haugeberg G
Age Ageing; 2012 Jan; 41(1):86-92. PubMed ID: 21896555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
